...
首页> 外文期刊>Internal medicine. >Mixed-type Multicentric Castleman's Disease Developing during a 17-year Follow-up of Sarcoidosis
【24h】

Mixed-type Multicentric Castleman's Disease Developing during a 17-year Follow-up of Sarcoidosis

机译:在结节病的17年随访中发生混合型多中心Castleman病

获取原文
           

摘要

Multicentric Castleman's Disease (MCD) is a systemic disease characterized by generalized lymphadenopathy and the proliferation of plasma cells. The development of MCD in a patient with preexisting sarcoidosis has not been previously reported. We herein describe a case of MCD developing in a 78-year-old woman with a 17-year history of sarcoidosis. The patient's serum interleukin-6 (IL-6) levels were only slightly elevated; however, the IL-6 levels in the fluid of both pleural effusion and ascites were markedly elevated. The administration of steroid-pulse therapy and prednisolone was ineffective in treating the MCD, although treatment with tocilizumab proved highly effective.
机译:多中心Castleman病(MCD)是一种全身性疾病,其特征是全身性淋巴结病和浆细胞增殖。以前没有结节病患者MCD的发展。我们在本文中描述了一名78岁结节病病史的78岁女性中发展为MCD的病例。患者的血清白介素6(IL-6)水平仅略有升高;然而,胸腔积液和腹水的IL-6水平明显升高。尽管使用托珠单抗治疗非常有效,但类固醇脉冲疗法和泼尼松龙的治疗无效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号